Restricted accessResearch articleFirst published online 2016
Moving from the Dish to the Clinical Practice: A Decade of Lessons and Perspectives from the Pre-Clinical and Clinical Stem Cell Studies for Alzheimer’s Disease
To date, there is no definitive treatment for Alzheimer’s disease (AD). The realm of stem cells is very promising in regenerative medicine, particularly neurodegenerative disorders. Various types of stem cells have been used in multiple trials on AD models, trying to find an innovative management of this disease. In this systematic review, we trace the published preclinical and clinical data throughout the last decade, to show how much knowledge we gained so far in this field and the future perspectives of stem cells in AD treatment.
LajthaLG, GilbertCW, PorteousDD, AexanianR (1964) Kinetics of a bone-marrow stem-cell population. Ann N Y Acad Sci113, 742–752.
5.
Lo SiccoC, TassoR, ReverberiD, CilliM, PfefferU, CanceddaR (2015) Identification of a new cell population constitutively circulating in healthy conditions and endowed with a homing ability toward injured sites. Sci Rep5, 16574.
6.
BuzhorE, LeshanskyL, BlumenthalJ, BarashH, WarshawskyD, MazorY, ShtrichmanR (2014) Cell-based therapy approaches: The hope for incurable diseases. Regen Med9, 649–672.
7.
ParkYJ, ChaS, ParkYS (2016) Regenerative applications using tooth derived stem cells in other than tooth regeneration: A literature review. Stem Cells Int2016, 9305986.
8.
MouhieddineTH, KobeissyFH, ItaniM, NokkariA, WangKKW (2014) Stem cells in neuroinjury and neurodegenerative disorders: Challenges and future neurotherapeutic prospects. Neural Regen Res9, 901–906.
9.
HebertLE, WeuveJ, ScherrPA, EvansDA (2013) Alzheimer disease in the United States (2010–2050) estimated using the 2010 census. Neurology80, 1778–1783.
10.
RosemannA (2015) Stem cell treatments for neurodegenerative diseases: Challenges from a science, business and healthcare perspective. Neurodegener Dis Manag5, 85–87.
KimbrelEA, LanzaR (2015) Current status of pluripotent stem cells: Moving the first therapies to the clinic. Nat Rev Drug Discov14, 681–692.
15.
PengY, HuangS, ChengB, NieX, EnheJ, FengC, FuX (2013) Mesenchymal stem cells: A revolution in therapeutic strategies of age-related diseases. Ageing Res Rev12, 103–115.
16.
BashD, SongL, TuanRS (2004) Adult mesenchymal stem cells: Characterization, differentiation, and application in cell and gene therapy. J Cell Mol Med8, 301–316.
17.
ChangKA, KimHJ, JooY, HaS, SuhYH (2014) The therapeutic effects of human adipose-derived stem cells in Alzheimer’s disease mouse models. Neurodegener Dis13, 99–102.
18.
MareiHES, AlthaniA, AfifiN, Abd-ElmaksoudA, BernardiniCFM, PescatoriM, MairaG, PaldinoE, ManniL, CasalboreP, CenciarelliC (2013) Over-expression of hNGF in adult human olfactory bulb neural stem cells promotes cell growth and oligodendrocytic differentiation. PLoS One8, e82206.
19.
YunHM, KimHS, ParkKR, ShinJM, KangAR, il LeeK, SongS, KimYB, HanSB, ChungHM, HongJT (2013) Placenta-derived mesenchymal stem cells improve memory dysfunction in an Aβ1-42-infused mouse model of Alzheimer’s disease. Cell Death Dis4, e958.
20.
YangH, YangH, XieZ, WeiL, BiJ (2013) Systemic transplantation of human umbilical cord derived mesenchymal stem cells-educated T regulatory cells improved the impaired cognition in AβPPswe/PS1dE9 transgenic mice. PLoS One8, e69129.
21.
KimKS, KimHS, ParkJM, KimHW, ParkMK, LeeHS, LimDS, LeeTH, ChoppM, MoonJ (2013) Long-term immunomodulatory effect of amniotic stem cells in an Alzheimer’s disease model. Neurobiol Aging34, 2408–2420.
22.
MajkaSM, JacksonKA, KienstraKA, MajeskyMW, GoodellMA, HirschiKK (2003) Distinct progenitor populations in skeletal muscle are bone marrow derived and exhibit different cell fates during vascular regeneration. J Clin Invest111, 71–79.
23.
BirchAM, KatsouriL, SastreM (2014) Modulation of inflammation in transgenic models of Alzheimer’s disease. Neuroinflammation11, 25.
24.
LeeHJ, LeeJK, LeeH, CarterJE, ChangJW, OhW, YangYS, SuhJG, LeeBH, JinHK, BaeJS (2012) Human umbilical cord blood-derived mesenchymal stem cells improve neuropathology and cognitive impairment in an Alzheimer’s disease mouse model through modulation of neuroinflammation. Neurobiol Aging33, 588–602.
25.
OhSH, KimHN, ParkHJ, ShinJY, LeePH (2015) Mesenchymal stem cells increase hippocampal neurogenesis and neuronal differentiation by enhancing the Wnt signaling pathway in an Alzheimer’s disease model. Cell Transplant24, 1097–1109.
26.
GarciaKO, OrnellasFL, MartinPK, PattiCL, MelloLE, Frussa-FilhoR, HanSW, LongoBM (2014) Therapeutic effects of the transplantation of VEGF overexpressing bone marrow mesenchymal stem cells in the hippocampus of murine model of Alzheimer’s disease. Front Aging Neurosci6, 30.
27.
BaeJS, JinHK, LeeJK, RichardsonJC, CarterJE (2013) Bone marrow-derived mesenchymal stem cells contribute to the reduction of amyloid-β deposits and the improvement of synaptic transmission in a mouse model of pre-dementia Alzheimer’s disease. Curr Alzheimer Res10, 524–531.
28.
KanamaruT, KamimuraN, YokotaT, NishimakiK, IuchiK, LeeH, TakamiS, AkashibaH, ShitakaY, UedaM, KatsuraK, KimuraK, OhtaS (2015) Intravenous transplantation of bone marrow-derived mononuclear cells prevents memory impairment in transgenic mouse models of Alzheimer’s disease. Brain Res1605, 49–58.
29.
ShinJW, LeeJK, LeeJE, MinWK, SchuchmanEH, JinHK, BaeJS (2011) Combined effects of hematopoietic progenitor cell mobilization from bone marrow by granulocyte colony stimulating factor and AMD3100 and chemotaxis into the brain using stromal cell-derived factor-1α in an Alzheimer’s disease mouse model. Stem Cells29, 1075–1089.
30.
BarkholtL, FloryE, JekerleV, Lucas-SamuelS, AhnertP, BissetL, BüscherD, FibbeW, FoussatA, KwaM, LantzO, MačiulaitisR, PalomäkiT, SchneiderCK, SensebéL, TachdjianG, TarteK, ToscaL, SalmikangasP, Capilla-GonzalezV, LavellE, Quiñones-HinojosaA, Guerrero-CazaresH (2015) Regulation of subventricular zone-derived cells migration in the adult brain. Adv Exp Med Biol853, 1–21.
31.
WageyR, ShortB (2014) Mesenchymal stem and progenitor cells: Problems, potential and promise. J Stem Cells Res Rev Rep1, 106.
32.
Capilla-GonzalezV, Herranz-PérezV, García-VerdugoJM (2015) The aged brain: Genesis and fate of residualrogenitor cells in the subventricular zone. Front Cell Neurosci9, 365.
33.
HamptonDW, WebberDJ, BilicanB, GoedertM, SpillantiniMG, ChandranS (2010) Cell-mediated neuroprotection in a mouse model of human tauopathy. J Neurosci30, 9973–9983.
34.
SpencerB, MarrRA, RockensteinE, CrewsL, AdameA, PotkarR, PatrickC, GageFH, VermaIM, MasliahE (2008) Long-term neprilysin gene transfer is associated with reduced levels of intracellular Abeta and behavioral improvement in APP transgenic mice. BMC Neurosci9, 109.
35.
MeilandtWJ, CisseM, HoK, WuT, EspositoLA, Scearce-LevieK, ChengIH, YuGQ, MuckeL (2009) Neprilysin overexpression inhibits plaque formation but fails to reduce pathogenic Abeta oligomers and associated cognitive deficits in human amyloid precursor protein transgenic mice. J Neurosci29, 1977–1986.
36.
Blurton-JonesM, SpencerB, MichaelS, CastelloNA, AgazaryanAA, DavisJL, MüllerFJ, LoringJF, MasliahE, LaFerlaFM (2014) Neural stem cells genetically-modified to express neprilysin reduce pathology in Alzheimer transgenic models. Stem Cell Res Ther5, 46.
37.
MoghadamFH, AlaieH, KarbalaieK, TanhaeiS, Nasr EsfahaniMH, BaharvandH (2009) Transplantation of primed or unprimed mouse embryonic stem cell-derived neural precursor cells improves cognitive function in Alzheimerian rats. Differentiation78, 59–68.
38.
LiuF, XuanA, ChenY, ZhangJ, XuL, YanQ, LongD (2014) Combined effect of nerve growth factor and brain-derived neurotrophic factor on neuronal differentiation of neural stem cells and the potential molecular mechanisms. Mol Med Rep10, 1739–1745.
39.
ZhangQ, WuHH, WangY, GuGJ, ZhangW, XiaR (2016) Neural stem cell transplantation decreases neuroinflammation in a transgenic mouse model of Alzheimer’s disease. J Neurochem136, 815–825.
40.
ZhangW, GuGJ, ShenX, ZhangQ, WangGM, WangPJ (2015) Neural stem cell transplantation enhances mitochondrial biogenesis in a transgenic mouse model of Alzheimer’s disease-like pathology. Neurobiol Aging36, 1282–1292.
41.
KimJA, HaS, ShinKY, KimS, LeeKJ, ChongYH, ChangKA, SuhYH (2015) Neural stem cell transplantation at critical period improves learning and memory through restoring synaptic impairment in Alzheimer’s disease mouse model. Cell Death Dis6, e1789.
42.
AgerRR, DavisJL, AgazaryanA, BenaventeF, PoonWW, LaFerlaFM, Blurton-JonesM (2015) Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of Alzheimer’s disease and neuronal loss. Hippocampus25, 813–826.
43.
SeabergRM, van der KooyD (2003) Stem and progenitor cells: The premature desertion of rigorous definitions. Trends Neurosci26, 125–131.
44.
GiuntaB, FernandezF, NikolicWV, ObregonD, RrapoE, TownT, TanJ (2008) Inflammaging as a prodrome to Alzheimer’s disease. J Neuroinflammation5, 51.
45.
RomanovYA, SvintsitskayaVA, SmirnovVN (2003) Searching for alternative sources of postnatal human mesenchymal stem cells: Candidate MSC-like cells from umbilical cord. Stem Cells21, 105–110.
46.
EndeN, ChenR, Ende-HarrisD (2001) Human umbilical cord blood cells ameliorate Alzheimer’s disease in transgenic mice. J Med32, 241–247.
47.
VendrameM, CassadyJ, NewcombJ, ButlerT, PennypackerKR, ZigovaT, SanbergCD, SanbergPR, WillingAE (2004) Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume. Stroke35, 2390–2395.
48.
DarlingtonD, DengJ, GiuntaB, HouH, SanbergCD, Kuzmin-NicholsN, ZhouHD, MoriT, EhrhartJ, SanbergPR, TanJ (2013) Multiple low-dose infusions of human umbilical cord blood cells improve cognitive impairments and reduce amyloid-β-associated neuropathology in Alzheimer mice. Stem Cells Dev22, 412–421.
49.
HuangT, HeD, KleinerG, KuluzJ (2007) Neuron-like differentiation of adipose-derived stem cells from infant piglets in vitro. J Spinal Cord Med30(Suppl 1), S35–S40.
KimS, ChangKA, KimJa, ParkHG, RaJC, KimHS, SuhYH (2012) The preventive and therapeutic effects of intravenous human adipose-derived stem cells in Alzheimer’s disease mice. PLoS One7, e45757.
54.
EsmaeilzadeB, NobakhtM, JoghataeiMT, Rahbar RoshandelN, RasouliH, Samadi KuchaksaraeiA, HosseiniSM, NajafzadeN, AsalgooS, HejazianLB, Moghani GhoroghiF (2012) Delivery of epidermal neural crest stem cells (EPI-NCSC) to hippocamp in Alzheimer’s disease rat model. Iran Biomed J16, 1–9.
55.
TakahashiK, YamanakaS (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell126, 663–676.
56.
AweJP, LeePC, RamathalC, Vega-CrespoA, Durruthy-DurruthyJ, CooperA, KarumbayaramS, LowryWE, ClarkAT, ZackJA, SebastianoV, KohnDB, PyleAD, MartinMG, LipshutzGS, PhelpsPE, PeraRA, ByrneJA (2013) Generation and characterization of transgene-free human induced pluripotent stem cells and conversion to putative clinical-grade status. Stem Cell Res Ther4, 87.
57.
MenonS, ShailendraS, RendaA, LongakerM, QuartoN (2016) An overview of direct somatic reprogramming: The ins and outs of iPSCs. Int J Mol Sci17, pii, E141.
SmithDK, HeM, ZhangCL, ZhengJC (2016) The therapeutic potential of cell identity reprogramming for the treatment of aging-related neurodegenerative disorders. Prog Neurobiol. doi: 10.1016/j.pneurobio.2016.01.006
60.
RafiiMS, BaumannTL, BakayRA, OstroveJM, SiffertJ, FleisherAS, HerzogCD, BarbaD, PayM, SalmonDP, ChuY, KordowerJH, BishopK, KeatorD, PotkinS, BartusRT (2014) A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer’s disease. Alzheimers Dement10, 571–581.
61.
KimHJ, SeoSW, ChangJW, LeeJI, KimCH, ChinJ, ChoiSJ, KwonH, YunHJ, LeeJM, KimST, ChoeYS, LeeKH, NaDL (2015) Stereotactic brain injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer’s disease dementia: A phase 1 clinical trial. Alzheimers Dement (N Y)1, 95–102.
62.
WalkerJR, PacomaR, WatsonJ, OuW, AlvesJ, MasonDE, PetersEC, UrbinaHD, WelzelG, AlthageA, LiuB, TuntlandT, JacobsonLH, HarrisJL, SchumacherAM (2013) Enhanced proteolytic clearance of plasma Aβ by peripherally administered neprilysin does not result in reduced levels of brain Aβ in mice. J Neurosci33, 2457–2464.
EhrhartJ, DarlingtonD, Kuzmin-NicholsN, SanbergCD, SawmillerDR, SanbergPR, TanJ (2016) Biodistribution of infused human umbilical cord blood cells in Alzheimer’s disease-like murine model. Cell Transplant25, 195–199.
67.
KamiyaN, UedaM, IgarashiH, NishiyamaY, SudaS, OkuboS, InabaT, KatayamaY (2013) In vivo monitoring of arterially transplanted bone marrow mononuclear cells in a rat transient focal brain ischemia model using magnetic resonance imaging. Neurol Res35, 573–579.
68.
ToyoshimaA, YasuharaT, KamedaM, MorimotoJ, TakeuchiH, WangF, SasakiT, SasadaS, ShinkoA, WakamoriT, OkazakiM, KondoA, AgariT, BorlonganCV, DateI (2015) Intra-arterial transplantation of allogeneic mesenchymal stem cells mounts neuroprotective effects in a transient ischemic stroke model in rats: Analyses of therapeutic time window and its mechanisms. PLoS One10, e0127302.
69.
CerriS, GrecoR, LevandisG, GhezziC, MangioneAS, Fuzzati-ArmenteroMT, BonizziA, AvanziniMA, MaccarioR, BlandiniF (2015) Intracarotid infusion of mesenchymal stem cells in an animal model of Parkinson’s disease, focusing on cell distribution and neuroprotective and behavioral effects. Stem Cells Transl Med4, 1073–1085.
70.
PodusloJF, HultmanKL, CurranGL, PreboskeGM, ChamberlainR, MarjańskaM, GarwoodM, JackCRJr, WengenackTM (2011) Targeting vascular amyloid in arterioles of Alzheimer disease transgenic mice with amyloid β protein antibody-coated nanoparticles. J Neuropathol Exp Neurol70, 653–661.
71.
PodusloJF, RamakrishnanM, HolasekSS, Ramirez-AlvaradoM, KandimallaKK, GillesEJ, CurranGL, WengenackTM (2007) In vivo targeting of antibody fragments to the nervous system for Alzheimer’s disease immunotherapy and molecular imaging of amyloid plaques. J Neurochem102, 420–433.
72.
DanielyanL, Beer-HammerS, StolzingA, SchäferR, SiegelG, FabianC, KahleP, BiedermannT, LourhmatiA, BuadzeM, NovakovicA, ProkschB, GleiterCH, FreyWH, SchwabM (2014) Intranasal delivery of bone marrow-derived mesenchymal stem cells, macrophages, and microglia to the brain in mouse models of Alzheimer’s and Parkinson’s disease.S123-S. Cell Transplant23(Suppl 1), S123–S139.
73.
LeeJK, JinHK, BaeJS (2009) Bone marrow-derived mesenchymal stem cells reduce brain amyloid-beta deposition and accelerate the activation of microglia in an acutely induced Alzheimer’s disease mouse model. Neurosci Lett450, 136–141.
74.
LeeJK, JinHK, EndoS, SchuchmanEH, CarterJE, BaeJS (2010) Intracerebral transplantation of bone marrow-derived mesenchymal stem cells reduces amyloid-beta deposition and rescues memory deficits in Alzheimer’s disease mice by modulation of immune responses. Stem Cells28, 329–343.
75.
HickmanSE, AllisonEK, El KhouryJ (2008) Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer’s disease mice. J Neurosci28, 8354–8360.
76.
Blurton-JonesM, KitazawaM, Martinez-CoriaH, CastelloNA, MüllerFJ, LoringJF, YamasakiTR, PoonWW, GreenKN, LaFerlaFM (2009) Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc Natl Acad Sci U S A106, 13594–13599.
77.
EnnisWJ, SuiA, BartholomewA (2013) Stem cells and healing: Impact on inflammation. Adv Wound Care (New Rochelle)2, 369–378.
78.
ZhangR, LiuY, YanK, ChenL, ChenXR, LiP, ChenFF, JiangXD (2013) Anti-inflammatory and immunomodulatory mechanisms of mesenchymal stem cell transplantation in experimental traumatic brain injury. J Neuroinflammation10, 106.
79.
KyurkchievD, BochevI, Ivanova-TodorovaE, MourdjevaM, OreshkovaT, BelemezovaK, KyurkchievS (2014) Secretion of immunoregulatory cytokines by mesenchymal stem cells. World J Stem Cells6, 552–570.
80.
Ruiz de AlmodovarC, LambrechtsD, MazzoneM, CarmelietP (2009) Role and therapeutic potential of VEGF in the nervous system. Physiol Rev89, 607–648.
81.
PaulG, AnisimovSV (2013) The secretome of mesenchymal stem cells: Potential implications for neuroregeneration. Biochimie95, 2246–2256.
82.
HanC, SunX, LiuL, JiangH, ShenY, XuX, LiJ, ZhangG, HuangJ, LinZ, XiongN, WangT (2016) Exosomes and their therapeutic potentials of stem cells. Stem Cells Int2016, 7653489.
83.
KonalaVB, MamidiMK, BhondeR, DasAK, PochampallyR, PalR (2016) The current landscape of the mesenchymal stromal cell secretome: A new paradigm for cell-free regeneration. Cytotherapy18, 13–24.
84.
CassarP, BlundellR (2016) The use of umbilical stem cells. Open J Pathol6, 41–56.
85.
Salido-GuadarramaI, Romero-CordobaS, Peralta-ZaragozaO, Hidalgo-MirandaA, Rodríguez-DorantesM (2014) MicroRNAs transported by exosomes in body fluids as mediators of intercellular communication in cancer. Onco Targets Ther7, 1327–1338.
86.
ChungJ, YangPC (2010) Molecular imaging of stem cell transplantation in myocardial disease. Curr Cardiovasc Imaging Rep3, 106–112.
87.
DianaV, BossolascoP, MoscatelliD, SilaniV, CovaL (2013) Dose dependent side effect of superparamagnetic iron oxide nanoparticle labeling on cell motility in two fetal stem cell populations. PLoS One8, e78435.
88.
VillaC, ErraticoS, RaziniP, FariniA, MeregalliM, BelicchiM, TorrenteY (2011) In vivo tracking of stem cell by nanotechnologies: Future prospects for mouse to human translation. Tissue Eng Part B Rev17, 1–11.
89.
LiX, LiuX, ShiD, WenX (2015) Particle systems for stem cell applications. J Biomed Nanotechnol11, 1107–1123.
90.
ChengSH, YuD, TsaiHM, MorshedRA, KanojiaD, LoLW, LeoniL, GovindY, ZhangL, AboodyKS, LesniakMS, ChenCT, BalyasnikovaIV (2015) Dynamic in vivo SPECT imaging of neural stem cells functionalized with radiolabeled nanoparticles for tracking of glioblastoma. J Nucl Med57, 279–284.
91.
KimJS, KimYH, KimJH, KangKW, TaeEL, YounH, KimD, KimSK, KwonJT, ChoMH, LeeYS, JeongJM, ChungJK, LeeDS (2012) Development and in vivo imaging of a PET/MRI nanoprobe with enhanced NIR fluorescence by dye encapsulation. Nanomedicine (Lond)7, 219–229.
92.
YangB, BrahmbhattA, Nieves TorresE, ThielenB, McCallDL, EngelS, BansalA, PandeyMK, DietzAB, LeofEB, DeGradoTR, MukhopadhyayD, MisraS (2016) Tracking and therapeutic value of human adipose tissue-derived mesenchymal stem cell transplantation in reducing venous neointimal hyperplasia associated with arteriovenous fistula. Radiology279, 513–522.
93.
NagarajanS, ZhangY (2011) Upconversion fluorescent nanoparticles as a potential tool for in-depth imaging. Nanotechnology22, 395101.
94.
RosenholmJM, Gulin-SarfrazT, MamaevaV, NiemiR, ÖzliseliE, DesaiD, AntfolkD, von HaartmanE, LindbergD, PrabhakarN, NäreojaT, SahlgrenC (2016) Prolonged dye release from mesoporous silica-based imaging probes facilitates long-term optical tracking of cell populations in vivo. Small12, 1578–1592.
95.
PageMJ, LourençoAL, DavidT, LeBeauAM, CattaruzzaF, CastroHC, VanBrocklinHF, CoughlinSR, CraikCS (2015) Non-invasive imaging and cellular tracking of pulmonary emboli by near-infrared fluorescence and positron-emission tomography. Nat Commun6, 8448.
96.
LehtivuoriH, BhattacharyaS, Angenent-MariNM, SatyshurKA, ForestKT (2015) Removal of chromophore-proximal polar atoms decreases water content and increases fluorescence in a near infrared phytofluor. Front Mol Biosci2, 65.
97.
WegnerKD, HildebrandtN (2015) Quantum dots: Bright and versatile in vitro and in vivo fluorescence imaging biosensors. Chem Soc Rev44, 4792–4834.
98.
Von der HaarK, LavrentievaA, StahlF, ScheperT, BlumeC (2015) Lost signature: Progress and failures in in vivo tracking of implanted stem cells. Appl Microbiol Biotechnol99, 9907–9922.
99.
ZhaoJY, ChenG, GuYP, CuiR, ZhangZL, YuZL, TangB, ZhaoYF, PangDW (2016) Ultrasmall magnetically engineered Ag2Se quantum dots for instant efficient labeling and whole-body high-resolution multimodal real-time tracking of cell-derived microvesicles. J Am Chem Soc138, 1893–1903.
IkonomovicMD, KlunkWE, AbrahamsonEE, MathisCA, PriceJC, TsopelasND, LoprestiBJ, ZiolkoS, BiW, PaljugWR, DebnathML, HopeCE, IsanskiBA, HamiltonRL, DeKoskyST (2008) Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer’s disease. Brain131(Pt 6), 1630–1645.
102.
KitazawaM, MedeirosR, LaferlaFM (2012) Transgenic mouse models of Alzheimer disease: Developing a better model as a tool for therapeutic interventions. Curr Pharm Des18, 1131–1147.
ChoiSH, KimYH, HebischM, SliwinskiC, LeeS, D’AvanzoC, ChenH, HooliB, AsselinC, MuffatJ, KleeJB, ZhangC, WaingerBJ, PeitzM, KovacsDM, WoolfCJ, WagnerSL, TanziRE, KimDY (2014) A three-dimensional human neural cell culture model of Alzheimer’s disease. Nature515, 274–278.
105.
D’AvanzoC, AronsonJ, KimYH, ChoiSH, TanziRE, KimDY (2015) Alzheimer’s in 3D culture: Challenges and perspectives. Bioessays37, 1139–1148.
106.
ZhangD, Pekkanen-MattilaM, ShahsavaniM, FalkA, TeixeiraAI, HerlandA (2014) A 3D Alzheimer’s disease culture model and the induction of P21-activated kinase mediated sensing in iPSC derived neurons. Biomaterials35, 1420–1428.
107.
GoldsteinLS, ReynaS, WoodruffG (2015) Probing the secrets of Alzheimer’s disease using human-induced pluripotent stem cell technology. Neurotherapeutics12, 121–125.
108.
WrightLS, PhillipsMJ, PinillaI, HeiD, GammDM (2014) Induced pluripotent stem cells as custom therapeutics for retinal repair: Progress and rationale. Exp Eye Res123, 161–172.
109.
Nakano-OkunoM, BorahBR, NakanoI (2014) Ethics of iPSC-based clinical research for age-related macular degeneration: Patient-centered risk-benefit analysis. Stem Cell Rev10, 743–752.
110.
RuzickaJ, Kulijewicz-NawrotM, Rodrigez-ArellanoJJ, JendelovaP, SykovaE (2016) Mesenchymal stem cells preserve working memory in the 3xTg-AD mouse model of Alzheimer’s disease. Int J Mol Sci17, pii, E152.
111.
XieZH, LiuZ, ZhangXR, YangH, WeiLF, WangY, XuSL, SunL, LaiC, BiJZ, WangXY (2016) Wharton’s Jelly-derived mesenchymal stem cells alleviate memory deficits and and reduce amyloid-β deposition in an APP/PS1 transgenic mouse model. Clin Exp Med16, 89–98.
112.
FujiwaraN, ShimizuJ, TakaiK, ArimitsuN, UedaY, WakisakaS, SuzukiT, SuzukiN (2015) Cellular and molecular mechanisms of the restoration of human APP transgenic mouse cognitive dysfunction after transplant of human iPS cell-derived neural cells. Exp Neurol271, 423–431.
113.
KimDH, LeeD, ChangEH, KimJH, HwangJW, KimJY, KyungJW, KimSH, OhJS, ShimSM, NaDL, OhW, ChangJW (2015) GDF-15 secreted from human umbilical cord blood mesenchymal stem cells delivered through the cerebrospinal fluid promotes hippocampal neurogenesis and synaptic activity in an Alzheimer’s disease model. Stem Cells Dev24, 2378–2390.
114.
LeeIS, JungK, KimIS, LeeH, KimM, YunS, HwangK, ShinJE, ParkKI (2015) Human neural stem cells alleviate Alzheimer-like pathology in a mouse model. Mol Neurodegener10, 38.
115.
ChenY, PanC, XuanA, XuL, BaoG, LiuF, FangJ, LongD (2015) Treatment efficacy of NGF nanoparticles combining neural stem cell transplantation on Alzheimer’s disease model rats. Med Sci Monit21, 3608–3615.
116.
SalemAM, AhmedHH, AttaHM, GhazyMA, AglanHA (2014) Potential of bone marrow mesenchymal stem cells in management of Alzheimer’s disease in female rats. Cell Biol Int38, 1367–1383.
117.
HaS, AhnS, KimS, JooY, ChongYH, SuhYH, ChangKA (2014) In vivo imaging of human adipose-derived stem cells in Alzheimer’s disease animal model. J Biomed Opt19, 051206.
118.
ChenSQ, CaiQ, ShenYY, WangPY, LiMH, TengGY (2014) Neural stem cell transplantation improves spatial learning and memory via neuronal regeneration in amyloid-β precursor protein/presenilin 1/tau triple transgenic mice. Am J Alzheimers Dis Other Demen29, 142–149.
119.
YanY, MaT, GongK, AoQ, ZhangX, GongY (2014) Adipose-derived mesenchymal stem cell transplantation promotes adult neurogenesis in the brains of Alzheimer’s disease mice. Neural Regen Res9, 798–805.
120.
KhairallahM, KassemLA, YassinNA, El DinMA, ZekriM, AttiaM (2014) The hematopoietic growth factor “erythropoietin” enhances the therapeutic effect of mesenchymal stem cells in Alzheimer’s disease. Pak J Biol Sci17, 9–21.
121.
GuG, WangP, ZhangW, LiM (2014) Effects of transplanted neural stem cells on synaptogenesis in APP/PS1 mice. Zhonghua Yi Xue Za Zhi94, 539–543.
122.
ZhangW, WangPJ, ShaHY, NiJ, LiMH, GuGJ (2014) Neural stem cell transplants improve cognitive function without altering amyloid pathology in an APP/PS1 double transgenic model of Alzheimer’s disease. Mol Neurobiol50, 423–437.
123.
ZhangW, WangGM, WangPJ, ZhangQ, ShaSH (2014) Effects of neural stem cells on synaptic proteins and memory in a mouse model of Alzheimer’s disease. J Neurosci Res92, 185–194.
124.
Ben-Menachem-ZidonO, Ben-MenahemY1, Ben-HurT2, YirmiyaR (2014) Intra-hippocampal transplantation of neural precursor cells with transgenic over-expression of IL-1 receptor antagonist rescues memory and neurogenesis impairments in an Alzheimer’s disease model. Neuropsychopharmacology39, 401–414.
125.
BobkovaNV, PoltavtsevaRA, SamokhinAN, SukhikhGT (2013) Therapeutic effect of mesenchymal multipotent stromal cells on memory in animals with Alzheimer-type neurodegeneration. Bull Exp Biol Med156, 119–121.
126.
ZhangW, WangPJ, GuGJ1, LiMH1, GaoXL (2013) Effects of neural stem cells transplanted into an animal model of Alzheimer disease on Aβ plaques. Zhonghua Yi Xue Za Zhi93, 3636–3639.
127.
LiWY, JinRL, HuXY (2012) Migration of PKH26-labeled mesenchymal stem cells in rats with Alzheimer’s disease. Zhejiang Da Xue Xue Bao Yi Xue Ban41, 659–664.
ChenSQ, CaiQ, ShenYY, WangPJ, TengGJ, LiMH, ZhangW, ZangFC (2012) (1)H-MRS evaluation of therapeutic effect of neural stem cell transplantation on Alzheimer’s disease in AβPP/PS1 double transgenic mice. J Alzheimers Dis28, 71–80.
130.
XueS, ChenC, DongW, HuiG, LiuT, GuoL (2012) Therapeutic effects of human amniotic epithelial cell transplantation on double-transgenic mice co-expressing APPswe and PS1ΔE9-deleted genes. Sci China Life Sci55, 132–140.
131.
ParkD, LeeHJ, JooSS, BaeDK, YangG, YangYH, LimI, MatsuoA, TooyamaI, KimYB, KimSU (2012) Human neural stem cells over-expressing choline acetyltransferase restore cognition in rat model of cognitive dysfunction. Exp Neurol234, 521–526.
132.
KlingePM, HarmeningK, MillerMC, HeileA, WallrappC, GeigleP, BrinkerT (2011) Encapsulated native and glucagon-like peptide-1 transfected human mesenchymal stem cells in a transgenic mouse model of Alzheimer’s disease. Neurosci Lett497, 6–10.
133.
XueSR, ChenCF, DongWL, HuiGZ, LiuTJ, GuoLH (2011) Intracerebroventricular transplantation of human amniotic epithelial cells ameliorates spatial memory deficit in the doubly transgenic mice coexpressing APPswe and PS1ΔE9-deleted genes. Chin Med J (Engl)124, 2642–2648.
134.
WenSR, QiHP, RenYJ, LiuGJ, GongFC, ZhongH, BiS (2011) Expression of δNp73 in hippocampus of APP/PS1 transgenic mice following GFP-BMSCs transplantation. Neurol Res33, 1109–1114.
135.
GongM, BiY, JiangW, ZhangY, ChenL, HouN, LiuY, WeiX, ChenJ, LiT (2011) Immortalized mesenchymal stem cells: An alternative to primary mesenchymal stem cells in neuronal differentiation and neuroregeneration associated studies. J Biomed Sci25, 87.
136.
LeeHJ, LeeJK, LeeH, ShinJW, CarterJE, SakamotoT, JinHK, BaeJS (2010) The therapeutic potential of human umbilical cord blood-derived mesenchymal stem cells in Alzheimer’s disease. Neurosci Lett481, 30–35.
137.
HeTT, ZhangJM, ShenL, YaoTL, TianJH (2010) Positron emission tomography imaging of cell transplantation in a rat model of Alzheimer’s disease. Zhongguo Yi Xue Ke Xue Yuan Xue Bao32, 210–214.
138.
RyuJK, ChoT, WangYT, McLarnonJG (2009) Neural progenitor cells attenuate inflammatory reactivity and neuronal loss in an animal model of inflamed AD brain. J Neuroinflammation6, 39.
139.
XuanAG, LuoM, JiWD, LongDH (2009) Effects of engrafted neural stem cells in Alzheimer’s disease rats. Neurosci Lett450, 167–171.
140.
XuanAG, LongDH, GuHG, YangDD, HongLP, LengSL (2008) BDNF improves the effects of neural stem cells on the rat model of Alzheimer’s disease with unilateral lesion of fimbria-fornix. Neurosci Lett440, 331–335.
141.
WuS, SasakiA, YoshimotoR, KawaharaY, ManabeT, KataokaK, AsashimaM, YugeL (2008) Neural stem cells improve learning and memory in rats with Alzheimer’s disease. Pathobiology75, 186–194.
142.
KoleckiR, LafauciG, RubensteinR, Mazur-KoleckaB, KaczmarskiW, FrackowiakJ (2008) The effect of amyloidosis-beta and ageing on proliferation of neuronal progenitor cells in APP-transgenic mouse hippocampus and in culture. Acta Neuropathol116, 419–424.
LiLY, LiJT, WuQY, LiJ, FengZT, LiuS, WangTH (2008) Transplantation of NGF-gene-modified bone marrow stromal cells into a rat model of Alzheimer’ disease. J Mol Neurosci34, 157–163.
145.
YamasakiTR, Blurton-JonesM, MorrissetteDA, KitazawaM, OddoS, LaFerlaFM (2007) Neural stem cells improve memory in an inducible mouse model of neuronal loss. J Neurosci27, 11925–11933.
146.
ZhanYQ, WangFR, LiFG, XingBZ, FangX, ZhangSM (2007) Study on distribution of neural stem cells in the brain of Alzheimer disease transgenic mice through caudal vein transplantation. Zhonghua Yi Xue Za Zhi87, 1786–1788.
147.
YangC, ZhangQ, WangSC, QiaoP, ZhangZ (2007) Neural stem cells transplantation improved learning and memory abilities in Alzheimer’s disease rat. Zhongguo Ying Yong Sheng Li Xue Za Zhi23, 159–161.
148.
WangQ, MatsumotoY, ShindoT, MiyakeK, ShindoA, KawanishiM, KawaiN, TamiyaT, NagaoS (2006) Neural stem cells transplantation in cortex in a mouse model of Alzheimer’s disease. J Med Invest53, 61–69.
149.
ZhaoZ, HuH, FengG (2006) Learning and memory amelioration of transplantation of the neural stem cells modified with human brain-derived neurotrophic factor gene on Alzheimer disease model rat. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi19, 331–334.
